BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23708585)

  • 21. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation.
    Zhao LN; Mu Y; Chew LY
    Phys Chem Chem Phys; 2013 Sep; 15(33):14098-106. PubMed ID: 23868536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the inter-molecular interactions in amyloid-β protofibril with molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area free energy calculations.
    Liu FF; Liu Z; Bai S; Dong XY; Sun Y
    J Chem Phys; 2012 Apr; 136(14):145101. PubMed ID: 22502547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of peptide inhibitors of soluble Aβ(1-42) oligomer formation by phage display.
    Kawasaki T; Onodera K; Kamijo S
    Biosci Biotechnol Biochem; 2010; 74(11):2214-9. PubMed ID: 21071869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudo-peptide amyloid-β blocking inhibitors: molecular dynamics and single molecule force spectroscopy study.
    Mehrazma B; Robinson M; Opare SKA; Petoyan A; Lou J; Hane FT; Rauk A; Leonenko Z
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt B):1707-1718. PubMed ID: 28844735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and dynamics of small soluble Aβ(1-40) oligomers studied by top-down hydrogen exchange mass spectrometry.
    Pan J; Han J; Borchers CH; Konermann L
    Biochemistry; 2012 May; 51(17):3694-703. PubMed ID: 22486153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
    Sheikh AM; Nagai A
    FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
    Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
    Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-β fibrillation.
    Skaat H; Chen R; Grinberg I; Margel S
    Biomacromolecules; 2012 Sep; 13(9):2662-70. PubMed ID: 22897679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new structural model of Aβ40 fibrils.
    Bertini I; Gonnelli L; Luchinat C; Mao J; Nesi A
    J Am Chem Soc; 2011 Oct; 133(40):16013-22. PubMed ID: 21882806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity.
    Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F
    Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
    Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
    FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energetic contributions of residues to the formation of early amyloid-β oligomers.
    Pouplana R; Campanera JM
    Phys Chem Chem Phys; 2015 Jan; 17(4):2823-37. PubMed ID: 25503571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disordered versus fibril-like amyloid β (25-35) dimers in water: structure and thermodynamics.
    Kittner M; Knecht V
    J Phys Chem B; 2010 Nov; 114(46):15288-95. PubMed ID: 20964446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alkali ion influence on structure and stability of fibrillar amyloid-β oligomers.
    Huraskin D; Horn AHC
    J Mol Model; 2019 Jan; 25(2):37. PubMed ID: 30637529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of graphene oxide on the conformational transitions of amyloid beta peptide: A molecular dynamics simulation study.
    Baweja L; Balamurugan K; Subramanian V; Dhawan A
    J Mol Graph Model; 2015 Sep; 61():175-85. PubMed ID: 26275931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite.
    Yu X; Wang Q; Lin Y; Zhao J; Zhao C; Zheng J
    Langmuir; 2012 Apr; 28(16):6595-605. PubMed ID: 22468636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
    Brown AM; Lemkul JA; Schaum N; Bevan DR
    Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational ensemble and polymorphism of the all-atom Alzheimer's Aβ(37-42) amyloid peptide oligomers.
    Nguyen PH; Derreumaux P
    J Phys Chem B; 2013 May; 117(19):5831-40. PubMed ID: 23581814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.